Evidence map›Paper›PMID 41195692›Full record

ArticleJournal of Parkinson's disease2025

Inter-relationship of the age of onset to the concept of brain-first versus body-first Parkinson's disease.

Leonidas Stefanis, Per Borghammer

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leonidas StefanisFirst Department of Neurology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Per BorghammerLundbeck Foundation Parkinson's Disease Research Center (PACE), Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The subtyping of Parkinson's Disease (PD) into brain-first and body-first PD has a powerful neuropathological, neuroimaging and clinical basis, supported by most relevant subsequent studies that have examined its validity. Here, we put forward the idea that the previous classification into early and late onset PD may be related to this categorization. The mean age of motor onset in brain-first PD may be up to 10 years earlier than body-first PD. Early onset PD has features related to brain-first PD, including relative clinical and nigrostriatal neurodegeneration asymmetry and a relatively restricted motor phenotype. In fact, PD as described by James Parkinson, could represent both early onset and brain-first PD, accounting for the famous phrase "senses and intellect uninjured". We suggest here that, at the population level, age of onset could be used as a proxy for brain-first vs body-first PD, notwithstanding the lack of a direct one-to-one correlation and of a clear dichotomy in early vs. late onset PD, which rather represents a continuum. This would enable large scale population studies into the underlying genetic and epidemiological basis of these presumed separate nosological entities. Along these lines, there are some indications of a divergent exposure and genetic basis in early vs. delayed onset PD, and body-first vs. body-first PD respectively. Thus, studies of the etiopathological basis of PD could examine data sets with clinical data limited to age of onset, keeping in mind that within the overall concept of sporadic PD there may be two qualitatively different disease processes.

Indexed as

BrainParkinson DiseaseAge of OnsetHumansasymmetrybody-firstbrain-firstearly onsetlate onsetParkinson's diseasesubtype

Identifiers

PMID41195692
PMCPMC13347523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.